Sign in

CIK 0001130166

  • Non-accelerated filer
  • Smaller reporting company

Bio Green Med Solution, Inc.

Sign in to watch
Tickers
BGMS BGMSP
Exchange
Nasdaq, OTC
Industry
Wholesale-Durable Goods, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911766850
Phone
+1 908-517-7330
Business address
200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
Former names
Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC

Securities

  • BGMS Common Stock Nasdaq
  • BGMSP Common stock OTC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Interim CEO sold 194,628,820 shares at $0.03 ($5,507,996)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 100,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Interim Chief Medical Officer acquired 12,500 shares (grant or award)
  13. 4 Open-market buy See Remarks bought 1,886 shares at $3.32 ($6,252)
  14. 4 Open-market buy President and CEO bought 6,070 shares at $3.32 ($20,122)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 21,219 shares (grant or award)
  17. 4 Grant or award Director acquired 21,219 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Director acquired 21,219 shares (grant or award)

Page 3 of 26 · 511 filings